Present and future of PET and PET/CT in gynaecologic malignancies

European Journal of Radiology

Volumn 78, Issue 1, 2011, Pages 12-20

  Musto, Alessandra ^a   Rampin, Lucia ^b   Nanni, Cristina ^a   Marzola, Maria Cristina ^b   Fanti, Stefano ^a   Rubello, Domenico ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

18F FDG; Gynaecological malignancies; Ovarian carcinoma; PET; PET CT; Uterus carcinoma

Indexed keywords

CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; ENDOMETRIUM CANCER; HUMAN; INTERMETHOD COMPARISON; OVARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERUS SARCOMA;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FORECASTING; GENITAL DISEASES, FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79954838572     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.12.035     Document Type: Article

References (53)

1. A.M. Maffione, M. Piva, and C.S. Tsamita Positron-emission tomography in gynaecologic malignancies Arch Gynecol Obstet 280 2009 521 528
2. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 2007 581 592 (Pubitemid 46359643)
3. C. Haie-Meder, P. Morice, M. Castiglione ESMO Guidelines Working Group Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl. 4 2009 iv27 iv28
4. S. Aebi, and M. Castiglione Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl. 4 2009 iv21 iv23
5. ACS: what are the key statistics about cervical cancer? http://www.cancer.org.
6. T.Z. Wong, E.L. Jones, and R.E. Coleman Role of positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer Mol Imaging Biol 238 2004 272 279
7. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 8 2007 1738 1744 (Pubitemid 47557298)
8. J.W. Roh, S.S. Seo, and S. Lee Role of positron emission tomography in pre-treatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study Eur J Cancer 41 2005 2086 2092 (Pubitemid 41337950)
9. J.D. Wright, F. Dehdashti, and T.J. Herzog Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-d-glucose- positron emission tomography Cancer 104 2005 2484 2491 (Pubitemid 41691572)
10. H.J. Choi, J.W. Roh, and S.S. Seo Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 2006 914 922 (Pubitemid 43238460)
11. S. Sironi, A. Buda, and M. Picchio Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT Radiology 238 January (1) 2006 272 279 (Pubitemid 43010605)
12. K. Narayan, R.J. Fisher, and D. Bernshaw Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent Int J Gynecol Cancer 19 July (5) 2009 912 918
13. J.K. Schwarz Association of post-therapy positron emission tomography with tumour response and survival in cervical carcinoma J Am Med Assoc 298 2007 2289 2295 (Pubitemid 350146219)
14. J.K. Schwarz, P.W. Grigsby, F. Dehdashti, and D. Delbeke The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries J Nucl Med 50 May (Suppl. 5) 2009 64S 73S
15. T.C. Yen, C.H. Lai, and S.Y. Ma Comparative benefits and limitations of (18)F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer Eur J Nucl Med Mol Imaging 33 2006 1399 1407
16. T.C. Yen, L.C. See, and T.C. Chang Defining the priority of using 18F-FDG PET for recurrent cervical cancer J Nucl Med 45 2004 1632 1639
17. H.H. Chung, S.B. Kang, and J.Y. Cho Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 2007 529 534 (Pubitemid 46240239)
18. E. Mittra, T. El-Maghraby, and C.A. Rodriguez Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma Eur J Nucl Med Mol Imaging 36 2009 1952 1959
19. S. Sironi, M. Picchio, and C. Landoni Post-therapy surveillance of patients with uterine cancer: value of integrated FDG PET/CT in the detection of recurrence Eur J Nucl Med Mol Imaging 34 2007 472 479 (Pubitemid 46426981)
20. K. Kitajima, K. Murakami, E. Yamasaki, Y. Kaji, and K. Sugimura Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2008 2040 2047
21. F.Y. Liu, T.C. Yen, and M.Y. Chen Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging Cancer 115 2009 5470 5480
22. M. Tatsumi, C. Cohade, R.E. Bristow, and R.L. Wahl Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET Mol Imaging Biol 11 2009 229 235
23. A. Chao, L.C. See, and C.H. Lai 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 2006 36 44 (Pubitemid 41785307)
24. K. Kitajima, K. Murakami, and E. Yamasaki Accuracy of PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer AJR Am J Roentgenol 190 2008 1652 1658 (Pubitemid 351798544)
25. D. Nayot, J.S. Kwon, M.S. Carey, and A. Driedger Does preoperative positron emission tomography with computed tomography predict nodal status in endometrial cancer? A pilot study Curr Oncol 15 3 2008 123 125
26. H.H. Chung, W.J. Kang, and J.W. Kim The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Med Mol Imaging 35 2008 1081 1088
27. Greer B. Comprehensive Cancer Network, NCCN Clinical practice guidelines in oncology: uterine neoplasms. www.nccn.org.
28. E.K. Nugent, I. Zighelboim, and A.S. Case The value of preoperative imaging in patients with uterine sarcomas Gynecol Oncol 115 2009 37 40
29. J.Y. Park, E.N. Kim, and D.Y. Kim Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma Gynecol Oncol. 109 2 2008 255 262
30. P.L. Sung, Y.J. Chen, and R.S. Liu Whole-body positron emission tomography with F-18 fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas Eur J Gynecol Oncol 29 2008 246 251 (Pubitemid 351744486)
31. American Cancer Society Cancer facts and figs 2009 2009 American Cancer Society Atlanta, GA
32. S. Pecorelli Carcinoma of the ovary J Epidemiol Biostat 3 1998 75 102
33. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529
34. American Cancer Society Cancer facts and figures: 1998 1998 American Cancer Society Atlanta, GA
35. P. Castellucci, A.M. Perrone, and M. Picchio Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology Nucl Med Commun 28 2007 589 595 (Pubitemid 47067045)
36. E.J. Nam, M.J. Yun, and Y.T. Oh Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI Gynecol Oncol 2009 10.1016/j.ygyno.2009.10.059
37. S. Risum, C. Høgdall, and A. Loft The diagnostic value of PET/CT for primary ovarian cancer - a prospective study Gynecol Oncol 105 2007 5 149
38. K. Kitajima, K. Murakami, and E. Yamasaki Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT Eur J Nucl Med Mol Imaging 35 2008 1912 1920
39. L. Funicelli, L.L. Travaini, F. Landoni, G. Trifir, L. Bonello, and M. Bellomi Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT Abdom Imaging 2009 10.1007/s00261-009-9578-8
40. A. Turlakov Peritoneal carcinomatosis: role of 18F-FDG PET J Nucl Med 44 2003 1407 1412
41. M. Picchio, S. Sironi, and C. Messa Advanced ovarian carcinoma: usefulness of 18[F]-FDG PET in combination with CT for lesion detection after primary treatment Q J Nucl Med 47 2003 77 84 (Pubitemid 36998713)
42. N. Avril, S. Sassen, and B. Schmalfeldt Prediction of response to neoadjuvant chemotherapy by sequential F-18-Fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer J Clin Oncol 30 23 2005 7445 7453 (Pubitemid 46291806)
43. Y. Nishiyama, Y. Yamamoto, and K. Kanenishi Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET Eur J Nucl Med Mol Imaging 35 2008 287 295
44. C. Nanni, D. Rubello, and M. Farsad 18F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients Eur J Surg Oncol 31 2005 792 797 (Pubitemid 41194659)
45. M.M. Thrall, J.A. DeLoia, H. Gallion, and N. Avril Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer Gynecol Oncol 105 2007 17 22 (Pubitemid 46441448)
46. R.E. Bristow, M.G. del Carmen, and H.K. Pannu Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecol Oncol 90 2003 519 528
47. R.E. Bristow, R.L. Giuntoli II, H.K. Pannu, R.D. Schulick, E.K. Fishman, and R.L. Wahl Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes Gynecol Oncol 99 2 2005 294 300 (Pubitemid 41502833)
48. M.J. Fulham, J. Carter, A. Baldey, R.J. Hicks, J.E. Ramshaw, and M. Gibson The impact of PET/CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project Gynecol Oncol 112 2009 462 468
49. S. Fanti, C. Nanni, and P. Castellucci Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding Cancer Imaging 6 2006 20 23
50. E. Gontier, M. Artski, J.M. Guinebretiere, and J.L. Alberini 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma AJR Am J Roentgen 187 2006 W285 W289
51. T. Torizuka, T. Kanno, and M. Futatsubashi Imaging of gynaecologic tumours: comparison of 11C-Choline PET with 18F-FDG PET J Nucl Med 44 2003 1051 1056 (Pubitemid 39663379)
52. T. Tsujikawa Uterine tumors: pathophysiologic imaging with 16-[18F]fluoro-17-betaestradiol and [18F]-Fluorodeoxyglucose PET - Initial experience Radiology 248 8 2008 599 605
53. 15O-PET for investigating perfusion changes in pelvic tumors due to regional hyperthermia Int J Hyperthermia 25 4 2009 299 308